Novartis Ag (NVS) Amortization - Intangibles (2009 - 2014)
Novartis Ag's (NVS) quarterly Amortization - Intangibles came in at -$2.9 billion in Q4 2014, up 4.17% year-over-year from -$2.7 billion in Q4 2013, and up 4.17% quarter-over-quarter from -$3.0 billion in Q4 2013.
Analysis
Novartis Ag (NVS) Amortization - Intangibles (2009 - 2014) Analysis & Trends
Novartis Ag has disclosed Amortization - Intangibles across 6 years of filings, most recently posting -$2.9 billion for Q4 2014.
- In Q4 2014, Amortization - Intangibles rose 4.17% year-over-year to -$2.9 billion; the TTM figure through Dec 2014 stood at -$11.8 billion (down 34.27% YoY), while the FY2023 annual figure was -$171.0 million, up 95.71% from the prior year.
- Amortization - Intangibles came in at -$2.9 billion for Q4 2014 at Novartis Ag, up from -$3.0 billion in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $164.0 million in Q1 2010 to a low of -$3.0 billion in Q4 2011.
- Average Amortization - Intangibles over 5 years is -$1.8 billion, with a median of -$2.9 billion recorded in 2014.
- Year-over-year, Amortization - Intangibles slumped 166.78% in 2011 and gained 4.43% in 2012.
- Over 5 years, Amortization - Intangibles stood at -$1.1 billion in 2010, then plunged by 166.78% to -$3.0 billion in 2011, then rose by 4.43% to -$2.9 billion in 2012, then decreased by 2.83% to -$3.0 billion in 2013, then gained by 4.17% to -$2.9 billion in 2014.
- Per Business Quant data, the three most recent Amortization - Intangibles figures were -$2.9 billion in Q4 2014, -$3.0 billion in Q4 2013, and -$2.9 billion in Q4 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2014 | -2.85 Bn |
| Dec 31, 2013 | -2.98 Bn |
| Dec 31, 2012 | -2.89 Bn |
| Dec 31, 2011 | -3.03 Bn |
| Mar 31, 2011 | 147.00 Mn |
| Dec 31, 2010 | -1.14 Bn |
| Mar 31, 2010 | 164.00 Mn |
| Dec 31, 2009 | -1.03 Bn |